Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1D | P25100 | 1/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 1/20 | 1.00 |
| ▸ | ADRA1B | P35368 | 1/20 | 1.00 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.42 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.42 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | DRD2 | P14416 | 1/20 | 0.41 |
| ▸ | DRD4 | P21917 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.41 |
| ▸ | PRCP | P42785 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.37 |
| ▸ | HTR1A | P08908 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Azapetine SCHEMBL29763084 | 1.00 | ADRA1D (1.00) | ADRA1DADRA1AADRA1BADRA2AADRA2B | |
| Azapetine SCHEMBL6763929 | 0.98 | ADRA1D (0.96) | ADRA1DADRA1AADRA1BADRA2AADRA2B | |
| Azapetine SCHEMBL5099699 | 0.90 | ADRA1D (0.81) | ADRA1DADRA1AADRA1BADRA2AADRA2B | |
| SCHEMBL2321445 | 0.90 | ADRA1D (0.81) | ADRA1DADRA1AADRA1BADRA2AADRA2B | |
| SCHEMBL4553041 | 0.88 | ADRA1D (0.77) | ADRA1DADRA1AADRA1BADRA2AADRA2B | |
| SCHEMBL23714081 | 0.79 | ADRA1D (0.65) | ADRA1DADRA1AADRA1BADRA2AADRA2B | |
| SCHEMBL3957205 | 0.77 | ADRA1D (0.62) | ADRA1DADRA1AADRA1BADRA2AADRA2B | |
| SCHEMBL23714130 | 0.77 | ADRA1D (0.62) | ADRA1DADRA1AADRA1BADRA2AADRA2B | |
| SCHEMBL4277150 | 0.76 | ADRA1D (0.61) | ADRA1DADRA1AADRA1BADRA2AADRA2B | |
| Bromide SCHEMBL6521671 | 0.76 | ADRA1D (0.61) | ADRA1DADRA1AADRA1BADRA2AADRA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120143879-A | Multi-agent unmanned aerial vehicle cluster collaborative search method based on semantic communication technology | 南京航空航天大学 | 2025-06-13 | — | — | CN | claimed |
| EP-3228314-A1 | VASODILATOR FOR USE TO TREAT MICROBIAL INFECTIONS | Helperby Therapeutics Limited (GB) | 2017-10-11 | — | — | EP | claimed |
| US-20160082073-A1 | NOVEL USE | HELPERBY THERAPEUTICS LIMITED (GB) | 2016-03-24 | — | — | US | claimed |
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| US-20130243886-A1 | NOVEL USE | HELPERBY THERAPEUTICS LIMITED (GB) | 2013-09-19 | — | — | US | claimed |
| EP-2613774-A2 | NOVEL USE | Helperby Therapeutics Limited (GB) | 2013-07-17 | — | — | EP | claimed |
| WO-2012032360-A2 | NOVEL USE | HELPERBY THERAPEUTICS LIMITED (GB) | 2012-03-15 | — | — | WO | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| CN-101330905-A | Freeze-drying process and products obtained thereby | SCIDOSE LLC (US) | 2008-12-24 | — | — | CN | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| US-6730691-B1 | OPHTHALMIC SOLUTION FOR INHIBITING VISUAL ANOMALIES EXPERIENCED BY AN INDIVIDUAL WHO UNDERGONE REFRACTIVE EYE SURGERY COMPRISING ALPHA ADRENERGIC BLOCKING AGENTS, ONE OR MORE ANTI-IRRITANT AGENTS, AND ONE OR MORE ANTI-INFLAMMATORY | GALIN MILES A (US) | 2004-05-04 | — | — | US | claimed |
| JP-2003535817-A | — | — | 2003-12-02 | — | — | JP | claimed |
| EP-1255540-A1 | OPHTHALMIC USE OF ALPHA ADRENERGIC BLOCKING AGENTS | Galin, Miles A. (US) | 2002-11-13 | — | — | EP | claimed |
| WO-2001058438-A1 | OPHTHALMIC USE OF ALPHA ADRENERGIC BLOCKING AGENTS | GALIN MILES A (US) | 2001-08-16 | — | — | WO | claimed |
| EP-0333769-A4 | COMBINATIONS OF RENAL VASODILATORS AND ALPHA 1-ADRENERGIC OR GANGLIONIC BLOCKING AGENTS FOR TREATING DISEASES. | NEW YORK MEDICAL COLLEGE (US) | 1990-06-27 | — | — | EP | claimed |
| EP-0333769-A1 | COMBINATIONS OF RENAL VASODILATORS AND ALPHA 1-ADRENERGIC OR GANGLIONIC BLOCKING AGENTS FOR TREATING DISEASES | NEW YORK MEDICAL COLLEGE (US) | 1989-09-27 | — | — | EP | claimed |
| WO-1988004179-A1 | COMBINATIONS OF RENAL VASODILATORS AND alpha1-ADRENERGIC OR GANGLIONIC BLOCKING AGENTS AND METHODS FOR TREATING DISEASES | NEW YORK MEDICAL COLLEGE (US) | 1988-06-16 | — | — | WO | claimed |
| US-4749686-A | Combinations of renal vasodilators and α1 -adrenergic or ganglionic blocking agents and methods for treating diseases | NEW YORK MEDICAL COLLEGE (US) | 1988-06-07 | — | — | US | claimed |